STARR CHRISTOPHER M - Insider Non-Derivative Transactions at Monopar Therapeutics (MNPR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 31, 2023, STARR CHRISTOPHER M's relationship to Monopar Therapeutics (MNPR) is Director, and currently has 25,863 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other MNPR insiders.
Data Source: SEC.
STARR CHRISTOPHER M - Insider Non-Derivative Transactions of MNPR Common Stock
STARR CHRISTOPHER M - Insider Non-Derivative Transactions at MNPR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 1, 2024 | M -- (Common Stock) | 2533 | 0 | 25863 |
| Oct 1, 2023 | M -- (Common Stock) | 2533 | 0 | 23330 |
| Jul 1, 2023 | M -- (Common Stock) | 2534 | 0 | 20797 |
| Apr 1, 2023 | M -- (Common Stock) | 2533 | 0 | 18263 |
| Jan 1, 2023 | M -- (Common Stock) | 2859 | 0 | 15730 |